Denali Therapeutics Inc.

DNLI

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001714899

SEC filings (opens in a new tab)

In the last 90 days, Denali Therapeutics Inc. insiders filed 0 open-market purchases and 4 sales; 294 institutions reported holding it in 13F filings for Q2 2026, worth $4.00B in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Denali Therapeutics Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023 All holders in Q4 2022

13F holders of DNLI: Q4 2022 compared with Q1 2023
Measure	Q4 2022	Of which not filed for Q1 2023	Q1 2023	Change
Holders	199	1	202	+4
Shares	105.9M	158	108.0M	+2.13M (+2.0%)
Value	$2.94B	$4.39K	$2.49B	−$456.7M (−15.5%)

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held Denali Therapeutics Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to DNLI in Q1 2023
Institution	Shares	Value	% of portfolio
Polar Capital Holdings Plc	505,000	$11.6M	0.09%
Eventide Asset Management, LLC	313,407	$7.22M	0.13%
Jefferies Financial Group Inc.	263,123	$6.06M	0.13%
Squarepoint Ops LLC	235,662	$5.43M	0.04%
Walleye Trading LLC	226,753	$5.22M	0.19%
Twinbeech Capital LP	149,302	$3.44M	0.07%
Woodline Partners LP	100,311	$2.31M	0.03%
Jump Financial, LLC	93,371	$2.15M	0.09%
Engineers Gate Manager LP	56,785	$1.31M	0.05%
Group One Trading, L.P.	49,760	$1.15M	0.05%
Ergoteles LLC	37,491	$863.8K	0.03%
Occudo Quantitative Strategies LP	29,221	$673.3K	0.06%
ExodusPoint Capital Management, LP	24,907	$574.0K	0.01%
Cerity Partners LLC	15,127	$348.5K	0.00%
Am Investment Strategies LLC	15,031	$346.0K	0.12%
Verition Fund Management LLC	11,782	$271.5K	0.00%
Dynamic Technology Lab Private Ltd	11,423	$263.0K	0.02%
Cetera Advisor Networks LLC	10,373	$239.0K	0.00%
AQR Capital Management LLC	9,201	$212.0K	0.00%
Campbell & CO Investment Adviser LLC	9,005	$207.5K	0.04%
Fox Run Management, L.L.C.	8,917	$205.4K	0.07%
Aquatic Capital Management LLC	3,800	$88.0K	0.01%
Ameritas Advisory Services, LLC	100	$2.30K	0.00%
Parallel Advisors, LLC	31	$714	0.00%
Toronto Dominion Bank	2	$0	0.00%
Baldrige Asset Management LLC	11	$0	0.00%

Sold out (22)

Institutions that held Denali Therapeutics Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of DNLI in Q1 2023
Institution	Shares, Q4 2022	Value, Q4 2022
Man Group plc	142,929	$3.97M
Point72 Asset Management, L.P.	64,400	$1.79M
Connor, Clark & Lunn Investment Management Ltd.	61,096	$1.70M
Bridgewater Associates, LP	14,970	$416.3K
Gotham Asset Management, LLC	13,029	$362.3K
Two Sigma Securities, LLC	12,306	$342.2K
XTX Topco Ltd	12,231	$340.1K
Aigen Investment Management, LP	10,751	$299.0K
Mackenzie Financial Corp	7,959	$221.3K
Ally Bridge Group (NY) LLC	4,479	$124.6K
Exchange Traded Concepts, LLC	2,584	$71.9K
Sandia Investment Management LP	2,500	$69.5K
Balyasny Asset Management LLC	1,313	$36.5K
High Net Worth Advisory Group LLC	1,000	$27.8K
Comerica Securities,inc.	225	$6.26K
Ellevest, Inc.	119	$3.31K
Leonteq Securities AG	50	$1.39K
Quadrant Capital Group LLC	40	$1.11K
IFP Advisors, Inc	15	$1.00K
Baker Avenue Asset Management, LP	22	$612
Sofos Investments, Inc.	28	$359
VitalStone Financial, LLC	15	$0

Not filed for Q1 2023 yet (1)

Institutions that held Denali Therapeutics Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DNLI in Q4 2022 that haven't filed for Q1 2023
Institution	Shares, Q4 2022	Value, Q4 2022
HealthInvest Partners AB	158	$4.39K